Evoke Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $408K | Sell |
916
-257
| -22% | -$114K | 0.01% | 375 |
|
|
2025
Q1 | $569K | Buy |
1,173
+102
| +10% | +$49.5K | 0.01% | 256 |
|
|
2024
Q4 | $431K | Buy |
1,071
+83
| +8% | +$33.4K | 0.01% | 286 |
|
|
2024
Q3 | $459K | Buy |
+988
| New | +$459K | 0.01% | 265 |
|
|
2024
Q2 | – | Sell |
-943
| Closed | -$394K | – | 388 |
|
|
2024
Q1 | $394K | Buy |
+943
| New | +$394K | 0.01% | 293 |
|
|
2022
Q4 | – | Sell |
-166
| Closed | -$48K | – | 1125 |
|
|
2022
Q3 | $48K | Hold |
166
| – | – | ﹤0.01% | 523 |
|
|
2022
Q2 | $47K | Sell |
166
-8
| -5% | -$2.27K | ﹤0.01% | 526 |
|
|
2022
Q1 | $45K | Buy |
174
+43
| +33% | +$11.1K | ﹤0.01% | 540 |
|
|
2021
Q4 | $29K | Hold |
131
| – | – | ﹤0.01% | 616 |
|
|
2021
Q3 | $23K | Sell |
131
-6
| -4% | -$1.05K | ﹤0.01% | 620 |
|
|
2021
Q2 | $28K | Sell |
137
-42
| -23% | -$8.58K | ﹤0.01% | 599 |
|
|
2021
Q1 | $38K | Buy |
179
+36
| +25% | +$7.64K | ﹤0.01% | 487 |
|
|
2020
Q4 | $34K | Buy |
143
+8
| +6% | +$1.9K | ﹤0.01% | 422 |
|
|
2020
Q3 | $37K | Hold |
135
| – | – | ﹤0.01% | 398 |
|
|
2020
Q2 | $39K | Sell |
135
-3
| -2% | -$867 | ﹤0.01% | 382 |
|
|
2020
Q1 | $32.8K | Sell |
138
-313
| -69% | -$74.5K | ﹤0.01% | 377 |
|
|
2019
Q4 | $98.7K | Sell |
451
-46
| -9% | -$10.1K | 0.01% | 324 |
|
|
2019
Q3 | $84.2K | Buy |
+497
| New | +$84.2K | 0.01% | 398 |
|